Harvard Pilgrim Health Care Home
  HPHConnect
 
  Learn more.
  Sign up for HPHConnect.
Medical Management
E-Transactions
HPHConnect
Pharmacy
For Your Patient
News Center
Network Matters
Newsletter Archives
Newsletter Registration
Newsroom
Office Support
Products
Provider Manual
Medicare Advantage
Research & Teaching
Resources & Links
 
Print    Text Size

Network Matters
News and Information for the
Harvard Pilgrim Health Care Network

January 2014

Update: Aloxi, Anzemet, and Emend Prior Authorization Medial Review Criteria 


Harvard Pilgrim has updated its Prior Authorization Medical Review Criteria for the medications Aloxi (palonosetron HCI injection), Anzemet (dolasetron mesylate), and Emend (fosaprepitant dimeglumine), which are used for treatment of nausea and vomiting. Effective March 14, 2014, all initial authorizations for ongoing treatment are limited to a maximum of six months.

Prior authorization is necessary to ensure that use of these medications is reasonable and necessary, clinically appropriate, and supported by evidence-based literature. To obtain a prior authorization, providers must submit the required written information and meet the criteria as specified in the Prior Authorization Medical Review Criteria for Aloxi, Anzemet, or Emend. When requesting authorization for these medications, please complete Harvard Pilgrim’s Medical Benefit Drugs Prior Authorization Request form and fax it to us at 800-232-0816.

For more information, refer to the Aloxi, Anzemet, and Emend Prior Authorization Medical Review Criteria.

Email this article to a colleague   

Receive Network Matters by e-mail

Network Matters Archives

Download printer-friendly version

HPHCURRENT EVENTS

Commitment to the Principles of Centered Care

Reminder: Electronic Funds Transfer is Now Available

CLINICIAN CORNER

Update: Aloxi, Anzemet, and Emend Prior Authorization Medial Review Criteria

New Medical Policy: Cell-free Fetal DNA Testing

Medical Policy for Genetic Testing

Reminder: Measures Aimed at Boosting SNF/PCP Care Coordination

P&T Committee Updates

Specialty Pharmacy Updates

Club Drugs: Emerging Trends and Patterns

OFFICE ASSISTANT

2014 Fee Schedule Updates

Update: Gastroenterology Payment Policy

New CMS 1500 Claim Form Now Accepted

PUBLICATION INFORMATION

Eric H. Schultz,
President and Chief Executive Officer

Richard Weisblatt PhD,
Senior Vice President, Provider Network

Annmarie Dadoly,
Editor

Kristin Edmonston,
Production Coordinator